ITRM vs PHM · rev $390.0K vs P/E 7.7, rev $17.95B
Iterum Therapeutics PLC (ITRM) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
ITRM currently screens at market cap $38.6M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the ITRM and PHM stock pages for the full models.
Not investment advice.